VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $765,000 | +16.4% | 31,150 | -4.5% | 0.30% | +24.2% |
| Q2 2016 | $657,000 | -19.1% | 32,615 | +5.6% | 0.24% | -16.7% |
| Q1 2016 | $812,000 | -69.4% | 30,890 | +18.2% | 0.29% | -65.3% |
| Q4 2015 | $2,656,000 | -6.2% | 26,130 | +64.7% | 0.83% | -12.3% |
| Q3 2015 | $2,831,000 | -23.1% | 15,870 | -4.2% | 0.95% | -19.9% |
| Q2 2015 | $3,681,000 | +0.5% | 16,570 | -10.1% | 1.18% | +7.5% |
| Q1 2015 | $3,661,000 | +22.1% | 18,430 | -12.0% | 1.10% | +24.2% |
| Q4 2014 | $2,999,000 | +16.7% | 20,955 | +7.0% | 0.88% | +16.4% |
| Q3 2014 | $2,569,000 | +6.2% | 19,580 | +2.1% | 0.76% | -4.8% |
| Q2 2014 | $2,419,000 | -2.1% | 19,180 | +2.4% | 0.80% | -8.5% |
| Q1 2014 | $2,470,000 | +22.8% | 18,735 | +9.4% | 0.87% | +25.1% |
| Q4 2013 | $2,011,000 | – | 17,125 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |